Latest Applied genetics Stories

IDENTIGENE Partners With Community Psychiatrist Dr. Janet Taylor to Educate Public on Healthy Approaches to Paternity Testing

2013-05-13 23:00:51

IDENTIGENE, the DNA testing laboratory that manufactures the #1 selling DNA paternity test sold at drugstores and supercenters, has signed psychiatrist and television personality Dr. Janet Taylor as their spokesperson for the first half of 2013. Salt Lake City, Utah (PRWEB) May 13, 2013 IDENTIGENE, the DNA testing laboratory that manufactures the #1 selling DNA paternity test sold at drugstores and supercenters, has signed psychiatrist and television personality Dr. Janet Taylor as their...

Natus Launches their New Paternity DNA Testing Services in London, UK

2013-05-11 23:03:59

Natus will be represented by 23DNA.co. (PRWEB) May 11, 2013 Paternity DNA testing services in London UK Find the answers you need - no matter where you live in the UK. May 1, 2013 - As a leader in DNA and maternity testing, Natus announces that they are now going to be providing paternity and DNA testing services to their London, UK customer and patient base. The company, that has 2500 US collection sites, is not only a leader in the US, but is also highly rated by patients, as the...

Family Tree DNA Offers mtDNA Test For $49

2013-05-09 12:28:32

-- Groundbreaking low pricing made possible by cutting-edge Next Generation Sequencing technology that is dramatically driving down costs -- HOUSTON, May 9, 2013 /PRNewswire/ -- FamilyTreeDNA.com, the genetic genealogy arm of Gene By Gene, Ltd., has lowered the price of its mid-level maternal line mtDNA test to $49, effective immediately. The company announced it will offer its mtDNAPlus product at a two-third price reduction permanently, in just its latest step toward universal...

DNA Saves Applauds Proposed Hatch Amendment to the Immigration Reform Bill

2013-05-08 08:31:50

-- Amendment Helps to Protect Victims, Enhance Public Safety -- CARLSBAD, N.M., May 8, 2013 /PRNewswire-USNewswire/ -- Jayann Sepich, mother of murder victim Katie Sepich, and founder of DNA Saves (www.DNASaves.org) expressed appreciation for Sen. Hatch's (Utah) proposal to require DNA samples from undocumented immigrants applying for a special residency status, and for his continued commitment to victim issues. "My daughter was murdered by someone in the United States illegally,"...

Natus Non Invasive Paternity Test is Now Available in New York

2013-05-06 23:25:03

The latest in non invasive testing, Natus is coming to New York. New York (PRWEB) May 06, 2013 Natus, a leader in paternity testing, has just announced that they will be providing new offices and non invasive testing solutions, to residents living in New York. The company, a leader in paternity testing in the US, already has 2500 offices located around the US, and will now provide women the opportunity to use their services, and the latest forms of non invasive testing options, in the New...

Discovery Of A Gene That Controls 3 Different Diseases

2013-04-25 20:27:17

The gene could also be involved in breast and ovarian cancer An international research consortium led by the Universitat Autònoma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered. The researchers, using next-generation massive ultrasequencing techniques, have sequenced the over 20,000 genes of a Fanconi anemia patient's genome. By adopting this strategy they...

ALS Trial Shows Novel Therapy Is Safe

2013-04-24 15:36:37

An investigational treatment for an inherited form of Lou Gehrig’s disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report. The researchers have shown that the therapy produced no serious side effects in patients with the disease, also known as amyotrophic lateral sclerosis (ALS). The phase 1 trial’s results, available online in Lancet Neurology, also demonstrate that the...

Ceregene Reports Data From Parkinson's Disease Phase 2b Study

2013-04-19 16:23:15

SAN DIEGO, April 19, 2013 /PRNewswire/ -- Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease. The trial did not demonstrate statistically significant efficacy on the primary endpoint (UPDRS-motor off). However, one of the "key secondary endpoints" (Diary-off score), as defined and...

Identigene Helps Fatherhood Matters Inc. with I.AM.A.FATHER Campaign

2013-03-29 23:15:04

On Saturday, April 6 from 2 p.m. to 4 p.m., Fatherhood Matters Inc., a San Antonio, Texas based non-profit organization will host I.AM.A.FATHER, an event in partnership with Identigene, providing a limited number of free DNA paternity tests to San Antonio families. The event is being held at the Boys & Girls Club of San Antonio. Salt Lake City, UT (PRWEB) March 29, 2013 On Saturday, April 6 from 2 p.m. to 4 p.m., Fatherhood Matters Inc., a San Antonio, Texas based non-profit...

Therapy Funded by The ALS Association Involving Injection of Antisense Molecules Into Spinal Cord Area of People with Lou Gehrig's Disease Deemed Safe in Recent Study

2013-03-29 12:21:19

WASHINGTON, March 29, 2013 /PRNewswire-USNewswire/ -- The injection of antisense molecules into the space around the spinal cord of people with ALS is safe according to research published today. The first-in-human trial of this new therapy was funded by The ALS Association. The study was published today in the scientific journal Lancet Neurology. ALS, also known as Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal...